Herpes simplex keratitis

Progress in Retinal and Eye Research

Volumn 25, Issue 4, 2006, Pages 355-380

  Kaye, Stephen ^a   Choudhary, Anshoo ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Corneal vascularisation; Herpes simplex keratitis; Herpes simplex virus; Latency associated transcripts

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; FAMCICLOVIR; STEROID; VALACICLOVIR; VIRUS PROTEIN;

CLINICAL FEATURE; CORNEA VASCULARIZATION; CYTOLOGY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; EYE DISEASE; GENE EXPRESSION; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; KERATOPLASTY; MORBIDITY; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SUPERINFECTION; VIRUS GENE; VIRUS GENOME; VIRUS LATENCY; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSCRIPTION; VISUAL IMPAIRMENT; WOUND HEALING;

ANIMALS; CORNEA; CORNEAL NEOVASCULARIZATION; GENES, VIRAL; HERPESVIRUS 1, HUMAN; HUMANS; KERATITIS, HERPETIC;

EID: 33745913652     PISSN: 13509462     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.preteyeres.2006.05.001     Document Type: Review

References (252)

1. Abghari S.Z., Stulting R.D., and Petrash J.M. Detection of herpes simplex virus type 1 latency-associated transcripts in corneal cells of inbred mice by in situ hybridization. Cornea 11 (1992) 433-438
2. Ahmed M., Lock M., Miller C.G., and Fraser N.W. Regions of the herpes simplex virus type 1 latency-associated transcript that protect cells from apoptosis in vitro and protect neuronal cells in vivo. J. Virol. 76 (2002) 717-729
3. Alvarado J.A., Underwood J.L., Green W.R., Wu S., Murphy C.G., Hwang D.G., Moore T.E., and O'Day D. Detection of herpes simplex viral DNA in the iridocorneal endothelial syndrome. Arch. Ophthalmol. 112 (1994) 1601-1609
4. Amano S., Oshika T., Kaji Y., Numaga J., Matsubara M., and Araie M. Herpes simplex virus in the trabeculum of an eye with corneal endotheliitis. Am. J. Ophthalmol. 127 (1999) 721-722
5. Armstrong L.C., and Bornstein P. Thrombospondins 1 and 2 function as inhibitors of angiogenesis. Matrix Biol. 22 (2003) 63-71
6. Asbell P.A., Centifanto-Fitzgerald Y.M., Chandler J.W., and Kaufman H.E. Analysis of viral DNA in isolates from patients with recurrent herpetic keratitis. Invest. Ophthalmol. Vis. Sci. 25 (1984) 951-954
7. Avery A.C., Zhao Z.S., Rodriguez A., Bikoff E.K., Soheilian M., Foster C.S., and Cantor H. Resistance to herpes stromal keratitis conferred by an IgG2a-derived peptide. Nature 376 (1995) 431-434
8. Babu J.S., Thomas J., Kanangat S., Morrison L.A., Knipe D.M., and Rouse B.T. Viral replication is required for induction of ocular immunopathology by herpes simplex virus. J. Virol. 70 (1996) 101-107
9. Barney N.P., and Foster C.S. A prospective randomized trial of oral acyclovir after penetrating keratoplasty for herpes simplex keratitis. Cornea 13 (1994) 232-236
10. Barron B.A., Gee L., Hauck W.W., Kurinij N., Dawson C.R., Jones D.B., Wilhelmus K.R., Kaufman H.E., Sugar J., and Hyndiuk R.A. Herpetic Eye Disease Study: a controlled trial of oral acyclovir for herpes simplex stromal keratitis. Ophthalmology 101 (1994) 1871-1882
11. Bauer D., Mrzyk S., Van R.N., Steuhl K.P., and Heiligenhaus A. Incidence and severity of herpetic stromal keratitis: impaired by the depletion of lymph node macrophages. Exp. Eye. Res. 72 (2001) 261-269
12. Bauer D., Mrzyk S., Van R.N., Steuhl K.P., and Heiligenhaus A. Macrophage-depletion influences the course of murine HSV-1 keratitis. Curr. Eye Res. 20 (2000) 45-53
13. Beigi B., Algawi K., Foley-Nolan A., and O'Keefe M. Herpes simplex keratitis in children. Br. J. Ophthalmol. 78 (1994) 458-460
14. Beneish R.G., Williams F.R., Polomeno R.C., and Flanders M.E. Herpes simplex keratitis and amblyopia. J. Pediatr. Ophthalmol. Strabismus 24 (1987) 94-96
15. Beyer C.F., Arens M.Q., Hill G.A., Rose B.T., Beyer L.R., and Schanzlin D.J. Oral acyclovir reduces the incidence of recurrent herpes simplex keratitis in rabbits after penetrating keratoplasty. Arch. Ophthalmol. 107 (1989) 1200-1205
16. Bialasiewicz A.A., and Jahn G.J. Systemic acyclovir therapy in recurrent keratouveitis caused by herpes simplex virus. Klin. Monatsbl. Augenheilkd. 185 (1984) 539-542
17. Binder P.S. Herpes simplex keratitis. Surv. Ophthalmol. 21 (1977) 313-331
18. Biswas P.S., Banerjee K., Kim B., and Rouse B.T. Mice transgenic for IL-1 receptor antagonist protein are resistant to herpetic stromal keratitis: possible role for IL-1 in herpetic stromal keratitis pathogenesis. J. Immunol. 172 (2004) 3736-3744
19. Biswas P.S., Banerjee K., Zheng M., and Rouse B.T. Counteracting corneal immunoinflammatory lesion with interleukin-1 receptor antagonist protein. J. Leukoc. Biol. 76 (2004) 868-875
20. Biswas P.S., Banerjee K., Kinchington P.R., and Rouse B.T. Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection. Exp. Eye Res 82 1 (2006) 46-54
21. Biswas S., Suresh P., Bonshek R.E., Corbitt G., Tullo A.B., and Ridgway A.E. Graft failure in human donor corneas due to transmission of herpes simplex virus. Br. J. Ophthalmol. 84 (2000) 701-705
22. Bloom D.C., Hill J.M., vi-Rao G., Wagner E.K., Feldman L.T., and Stevens J.G. A 348-base-pair region in the latency-associated transcript facilitates herpes simplex virus type 1 reactivation. J. Virol. 70 (1996) 2449-2459
23. Bornstein P., and Sage E.H. Matricellular proteins: extracellular modulators of cell function. Curr. Opin. Cell Biol. 14 (2002) 608-616
24. Bornstein P., Agah A., and Kyriakides T.R. The role of thrombospondins 1 and 2 in the regulation of cell-matrix interactions, collagen fibril formation, and the response to injury. Int. J. Biochem. Cell Biol. 36 (2004) 1115-1125
25. Boutell C., and Everett R.D. The herpes simplex virus type 1 (HSV-1) regulatory protein ICP0 interacts with and Ubiquitinates p53. J. Biol. Chem. 278 (2003) 36596-36602
26. Brandt C.R. The role of viral and host genes in corneal infection with herpes simplex virus type 1. Exp. Eye. Res. 80 (2005) 607-621
27. Brandt C.R., and Grau D.R. Mixed infection with herpes simplex virus type 1 generates recombinants with increased ocular and neurovirulence. Invest. Ophthalmol. Vis. Sci. 31 (1990) 2214-2223
28. Buchman T.G., Roizman B., Adams G., and Stover B.H. Restriction endonuclease fingerprinting of herpes simplex virus DNA: a novel epidemiological tool applied to a nosocomial outbreak. J. Infect. Dis. 138 (1978) 488-498
29. Cai W., and Schaffer P.A. Herpes simplex virus type 1 ICP0 regulates expression of immediate-early, early, and late genes in productively infected cells. J. Virol. 66 (1992) 2904-2915
30. Cai W., Astor T.L., Liptak L.M., Cho C., Coen D.M., and Schaffer P.A. The herpes simplex virus type 1 regulatory protein ICP0 enhances virus replication during acute infection and reactivation from latency. J. Virol. 67 (1993) 7501-7512
31. Cantin E.M., Chen J., McNeill J., Willey D.E., and Openshaw H. Detection of herpes simplex virus DNA sequences in corneal transplant recipients by polymerase chain reaction assays. Curr. Eye Res. 10 Suppl. (1991) 15-21
32. Cao Y., Chen C., Weatherbee J.A., Tsang M., and Folkman J. Gro-beta, a -C-X-C- chemokine, is an angiogenesis inhibitor that suppresses the growth of Lewis lung carcinoma in mice. J. Exp. Med. 182 (1995) 2069-2077
33. Carbone R., Pearson M., Minucci S., and Pelicci P.G. PML NBs associate with the hMre11 complex and p53 at sites of irradiation induced DNA damage. Oncogene 21 (2002) 1633-1640
34. Carr D.J., Harle P., and Gebhardt B.M. The immune response to ocular herpes simplex virus type 1 infection. Exp. Biol. Med. (Maywood) 226 (2001) 353-366
35. Carroll J.M., Martola E.L., Laibson P.R., and Dohlman C.H. The recurrence of herpetic keratitis following idoxuridine therapy. Am. J. Ophthalmol. 63 (1967) 103-107
36. Chee A.V., Lopez P., Pandolfi P.P., and Roizman B. Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects. J. Virol. 77 (2003) 7101-7105
37. Chelbi-Alix M.K., and De T.H. Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins. Oncogene 18 (1999) 935-941
38. Chen J., and Silverstein S. Herpes simplex viruses with mutations in the gene encoding ICP0 are defective in gene expression. J. Virol. 66 (1992) 2916-2927
39. Chen S.H., Kramer M.F., Schaffer P.A., and Coen D.M. A viral function represses accumulation of transcripts from productive-cycle genes in mouse ganglia latently infected with herpes simplex virus. J. Virol. 71 (1997) 5878-5884
40. Chong E.M., Wilhelmus K.R., Matoba A.Y., Jones D.B., Coats D.K., and Paysse E.A. Herpes simplex virus keratitis in children. Am. J. Ophthalmol. 138 (2004) 474-475
41. Choudhary A., Hiscott P., Hart C.A., Kaye S.B., Batterbury M., and Grierson I. Suppression of thrombospondin 1 and 2 production by herpes simplex virus 1 infection in cultured keratocytes. Mol. Vis. 11 (2005) 163-168
42. Cobo L.M., Coster D.J., Rice N.S., and Jones B.R. Prognosis and management of corneal transplantation for herpetic keratitis. Arch. Ophthalmol. 98 (1980) 1755-1759
43. Coen D.M., Schaffer P.A., Furman P.A., Keller P.M., and St Clair M.H. Biochemical and genetic analysis of acyclovir-resistant mutants of herpes simplex virus type 1. Am. J. Med. 73 (1982) 351-360
44. Colin J., Le G.M., Le G.A., Renard G., and Chastel C. [Ocular herpes simplex in children (author's transl)]. Ophthalmologica 184 (1982) 1-5
45. Collum L.M., O'Connor M., and Logan P. Comparison of the efficacy and toxicity of acyclovir and of adenine arabinoside when combined with dilute betamethasone in herpetic disciform keratitis: preliminary results of a double-blind trial. Trans. Ophthalmol. Soc. UK 103 Part 6 (1983) 597-599
46. Cook S.D., Aitken D.A., Loeffler K.U., and Brown S.M. Herpes simplex virus in the cornea; an ultrastructural study on viral reactivation. Trans. Ophthalmol. Soc. UK 105 Part 6 (1986) 634-641
47. Cook S.D., Hill J.M., Lynas C., and Maitland N.J. Latency-associated transcripts in corneas and ganglia of HSV-1 infected rabbits. Br. J. Ophthalmol. 75 (1991) 644-648
48. Crouse C.A., Pflugfelder S.C., Pereira I., Cleary T., Rabinowitz S., and Atherton S.S. Detection of herpes viral genomes in normal and diseased corneal epithelium. Curr. Eye. Res. 9 (1990) 569-581
49. Cunningham Jr. E.T. Diagnosing and treating herpetic anterior uveitis. Ophthalmology 107 (2000) 2129-2130
50. Daheshia M., Kanangat S., and Rouse B.T. Production of key molecules by ocular neutrophils early after herpetic infection of the cornea. Exp. Eye. Res. 67 (1998) 619-624
51. Darougar S., Wishart M.S., and Viswalingam N.D. Epidemiological and clinical features of primary herpes simplex virus ocular infection. Br. J. Ophthalmol. 69 (1985) 2-6
52. Dawson C.R., and Togni B. Herpes simplex eye infections: clinical manifestations, pathogenesis and management. Surv. Ophthalmol. 21 (1976) 121-135
53. Deshmane S.L., and Fraser N.W. During latency, herpes simplex virus type 1 DNA is associated with nucleosomes in a chromatin structure. J. Virol. 63 (1989) 943-947
54. Deshpande S., Zheng M., Lee S., Banerjee K., Gangappa S., Kumaraguru U., and Rouse B.T. Bystander activation involving T lymphocytes in herpetic stromal keratitis. J. Immunol. 167 (2001) 2902-2910
55. Dhaliwal D.K., Romanowski E.G., Yates K.A., Hu D., Goldstein M., and Gordon Y.J. Experimental laser-assisted in situ keratomileusis induces the reactivation of latent herpes simplex virus. Am. J. Ophthalmol. 131 (2001) 506-507
56. Dobson A.T., Sederati F., vi-Rao G., Flanagan W.M., Farrell M.J., Stevens J.G., Wagner E.K., and Feldman L.T. Identification of the latency-associated transcript promoter by expression of rabbit beta-globin mRNA in mouse sensory nerve ganglia latently infected with a recombinant herpes simplex virus. J. Virol. 63 (1989) 3844-3851
57. Easty D.L., Shimeld C., Claoue C.M., and Menage M. Herpes simplex virus isolation in chronic stromal keratitis: human and laboratory studies. Curr. Eye. Res. 6 (1987) 69-74
58. Edelhauser H.F., Schultz R.O., and Van Horn D.L. Experimental herpes simplex keratitis: corneal hydration, electrolyte content and structural changes. Am. J. Ophthalmol. 68 (1969) 458-466
59. Ellison A.R., Yang L., Cevallos A.V., and Margolis T.P. Analysis of the herpes simplex virus type 1 UL6 gene in patients with stromal keratitis. Virology 310 (2003) 24-28
60. Everett R.D. The products of herpes simplex virus type 1 (HSV-1) immediate early genes 1, 2 and 3 can activate HSV-1 gene expression in trans. J. Gen. Virol. 67 Part 11 (1986) 2507-2513
61. Everett R.D. DNA viruses and viral proteins that interact with PML nuclear bodies. Oncogene 20 (2001) 7266-7273
62. Everett R.D., and Maul G.G. HSV-1 IE protein Vmw110 causes redistribution of PML. EMBO J. 13 (1994) 5062-5069
63. Everett R.D., Freemont P., Saitoh H., Dasso M., Orr A., Kathoria M., and Parkinson J. The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms. J. Virol. 72 (1998) 6581-6591
64. Farhatullah S., Kaza S., Athmanathan S., Garg P., Reddy S.B., and Sharma S. Diagnosis of herpes simplex virus-1 keratitis using Giemsa stain, immunofluorescence assay, and polymerase chain reaction assay on corneal scrapings. Br. J. Ophthalmol. 88 (2004) 142-144
65. Farrell M.J., Dobson A.T., and Feldman L.T. Herpes simplex virus latency-associated transcript is a stable intron. Proc. Natl. Acad. Sci. USA 88 (1991) 790-794
66. Fine M., and Cignetti F.E. Penetrating keratoplasty in herpes simplex keratitis: recurrence in grafts. Arch. Ophthalmol. 95 (1977) 613-616
67. Foster C.S., and Duncan J. Penetrating keratoplasty for herpes simplex keratitis. Am. J. Ophthalmol. 92 (1981) 336-343
68. Fukuda M., Deai T., Hibino T., Higaki S., Hayashi K., and Shimomura Y. Quantitative analysis of herpes simplex virus genome in tears from patients with herpetic keratitis. Cornea 22 (2003) S55-S60
69. Fynan E.F., Webster R.G., Fuller D.H., Haynes J.R., Santoro J.C., and Robinson H.L. DNA vaccines: a novel approach to immunization. Int. J. Immunopharmacol. 17 (1995) 79-83
70. Garber D.A., Beverley S.M., and Coen D.M. Demonstration of circularization of herpes simplex virus DNA following infection using pulsed field gel electrophoresis. Virology 197 (1993) 459-462
71. Ghiasi H., Cai S., Slanina S.M., Perng G.C., Nesburn A.B., and Wechsler S.L. The role of interleukin (IL)-2 and IL-4 in herpes simplex virus type 1 ocular replication and eye disease. J. Infect. Dis. 179 (1999) 1086-1093
72. Ghiasi H., Cai S., Perng G.C., Nesburn A.B., and Wechsler S.L. Both CD4+ and CD8+ T cells are involved in protection against HSV-1 induced corneal scarring. Br. J. Ophthalmol. 84 (2000) 408-412
73. Ghiasi H., Cai S., Perng G.C., Nesburn A.B., and Wechsler S.L. The role of natural killer cells in protection of mice against death and corneal scarring following ocular HSV-1 infection. Antiviral Res. 45 (2000) 33-45
74. Grau D.R., Visalli R.J., and Brandt C.R. Herpes simplex virus stromal keratitis is not titer-dependent and does not correlate with neurovirulence. Invest. Ophthalmol. Vis. Sci. 30 (1989) 2474-2480
75. Groh M.J., Seitz B., Schumacher S., and Naumann G.O. Detection of herpes simplex virus in aqueous humor in iridocorneal endothelial (ICE) syndrome. Cornea 18 (1999) 359-360
76. Gunderson T. Herpes corneae with special reference to its treatment with strong solution of iodine. Arch. Ophthalmol. 15 (1936) 225-249
77. Henderson G., Peng W., Jin L., Perng G.C., Nesburn A.B., Wechsler S.L., and Jones C. Regulation of caspase 8- and caspase 9-induced apoptosis by the herpes simplex virus type 1 latency-associated transcript. J. Neurovirol. 8 Suppl. 2 (2002) 103-111
78. Herpetic Eye Disease Study Group (HEDS). A controlled trial of oral acyclovir for iridocyclitis caused by herpes simplex virus. Arch. Ophthalmol. 114 (1996) 1065-1072
79. Herpetic Eye Disease Study Group (HEDS). Acyclovir for the prevention of recurrent herpes simplex virus eye disease. N. Engl. J. Med. 339 (1998) 300-306
80. Herpetic Eye Disease Study Group (HEDS). Psychological stress and other potential triggers for recurrences of herpes simplex virus eye infections. Arch. Ophthalmol. 118 (2000) 1617-1625
81. Herpetic Eye Disease Study Group (HEDS). Predictors of recurrent herpes simplex virus keratitis. Cornea 20 (2001) 123-128
82. Herrera F.J., and Triezenberg S.J. VP16-dependent association of chromatin-modifying coactivators and underrepresentation of histones at immediate-early gene promoters during herpes simplex virus infection. J. Virol. 78 (2004) 9689-9696
83. Hill A., Jugovic P., York I., Russ G., Bennink J., Yewdell J., Ploegh H., and Johnson D. Herpes simplex virus turns off the TAP to evade host immunity. Nature 375 (1995) 411-415
84. Hill J.M., Sedarati F., Javier R.T., Wagner E.K., and Stevens J.G. Herpes simplex virus latent phase transcription facilitates in vivo reactivation. Virology 174 (1990) 117-125
85. Hiscott P., Armstrong D., Batterbury M., and Kaye S. Repair in avascular tissues: fibrosis in the transparent structures of the eye and thrombospondin 1. Histol. Histopathol. 14 (1999) 1309-1320
86. Holbach L.M., Font R.L., and Naumann G.O. Herpes simplex stromal and endothelial keratitis: granulomatous cell reactions at the level of Descemet's membrane, the stroma, and Bowman's layer. Ophthalmology 97 (1990) 722-728
87. Holbach L.M., Font R.L., Baehr W., and Pittler S.J. HSV antigens and HSV DNA in avascular and vascularized lesions of human herpes simplex keratitis. Curr. Eye Res. 10 Suppl. (1991) 63-68
88. Holland E.J., and Schwartz G.S. Classification of herpes simplex virus keratitis. Cornea 18 (1999) 144-154
89. Honda M., Okuda T., Hasegawa T., Kurokawa M., Shiraki K., Matsuo K., Komatsuzaki M., and Niimura M. Effect of long-term, low-dose acyclovir suppressive therapy on susceptibility to acyclovir and frequency of acyclovir resistance of herpes simplex virus type 2. Antiviral Chem. Chemother. 12 (2001) 233-239
90. Honess R.W., and Roizman B. Proteins specified by herpes simplex virus, XI: identification and relative molar rates of synthesis of structural and nonstructural herpes virus polypeptides in the infected cell. J. Virol. 12 (1973) 1347-1365
91. Honess R.W., and Roizman B. Regulation of herpesvirus macromolecular synthesis, I: cascade regulation of the synthesis of three groups of viral proteins. J. Virol. 14 (1974) 8-19
92. Honess R.W., and Roizman B. Regulation of herpesvirus macromolecular synthesis: sequential transition of polypeptide synthesis requires functional viral polypeptides. Proc. Natl. Acad. Sci. USA 72 (1975) 1276-1280
93. Hughes W.F. Treatment of herpes simplex keratitis: a review. Am. J. Ophthalmol. 67 (1969) 313-328
94. Ishov A.M., Sotnikov A.G., Negorev D., Vladimirova O.V., Neff N., Kamitani T., Yeh E.T., Strauss III J.F., and Maul G.G. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J. Cell Biol. 147 (1999) 221-234
95. Jackson S.A., and DeLuca N.A. Relationship of herpes simplex virus genome configuration to productive and persistent infections. Proc. Natl. Acad. Sci. USA 100 (2003) 7871-7876
96. Jager M.J., Bradley D., Atherton S., and Streilein J.W. Presence of Langerhans cells in the central cornea linked to the development of ocular herpes in mice. Exp. Eye Res. 54 (1992) 835-841
97. Jenuwein T., and Allis C.D. Translating the histone code. Science 293 (2001) 1074-1080
98. Jerome K.R., Fox R., Chen Z., Sarkar P., and Corey L. Inhibition of apoptosis by primary isolates of herpes simplex virus. Arch. Virol. 146 (2001) 2219-2225
99. Jin L., Peng W., Perng G.C., Brick D.J., Nesburn A.B., Jones C., and Wechsler S.L. Identification of herpes simplex virus type 1 latency-associated transcript sequences that both inhibit apoptosis and enhance the spontaneous reactivation phenotype. J. Virol. 77 (2003) 6556-6561
100. Jin L., Perng G.C., Brick D.J., Naito J., Nesburn A.B., Jones C., and Wechsler S.L. Methods for detecting the HSV-1 LAT anti-apoptosis activity in virus infected tissue culture cells. J. Virol. Methods 118 (2004) 9-13
101. Jin L., Perng G.C., Mott K.R., Osorio N., Naito J., Brick D.J., Carpenter D., Jones C., and Wechsler S.L. A herpes simplex virus type 1 mutant expressing a baculovirus inhibitor of apoptosis gene in place of latency-associated transcript has a wild-type reactivation phenotype in the mouse. J. Virol. 79 (2005) 12286-12295
102. Jordan C., Baron S., Dianzani F., Barber J., and Stanton G.J. Ocular herpes simplex virus infection is diminished by depletion of B lymphocytes. J. Immunol. 131 (1983) 1554-1557
103. Kaufman H.E., Azcuy A.M., Varnell E.D., Sloop G.D., Thompson H.W., and Hill J.M. HSV-1 DNA in tears and saliva of normal adults. Invest. Ophthalmol. Vis. Sci. 46 (2005) 241-247
104. Kaye S.B., and Baker K. Herpes simplex keratitis. J. Med. Microbiol. 45 (1996) 3-5
105. Kaye S.B., Madan N., Dowd T.C., Hart C.A., McCarthy K., and Patterson A. Ocular shedding of herpes simplex virus. Br. J. Ophthalmol. 74 (1990) 114-116
106. Kaye S.B., Lynas C., Patterson A., Risk J.M., McCarthy K., and Hart C.A. Evidence for herpes simplex viral latency in the human cornea. Br. J. Ophthalmol. 75 (1991) 195-200
107. Kaye S.B., Shimeld C., Grinfeld E., Maitland N.J., Hill T.J., and Easty D.L. Non-traumatic acquisition of herpes simplex virus infection through the eye. Br. J. Ophthalmol. 76 (1992) 412-418
108. Kaye S.B., Baker K., Bonshek R., Maseruka H., Grinfeld E., Tullo A., Easty D.L., and Hart C.A. Human herpes viruses in the cornea. Br. J. Ophthalmol. 84 (2000) 563-571
109. Khanna K.M., Bonneau R.H., Kinchington P.R., and Hendricks R.L. Herpes simplex virus-specific memory CD8+ T cells are selectively activated and retained in latently infected sensory ganglia. Immunity 18 (2003) 593-603
110. Kim B., Tang Q., Biswas P.S., Xu J., Schiffelers R.M., Xie F.Y., Ansari A.M., Scaria P.V., Woodle M.C., Lu P., and Rouse B.T. Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis. Am. J. Pathol. 165 (2004) 2177-2185
111. Kim B., Lee S., Suvas S., and Rouse B.T. Application of plasmid DNA encoding IL-18 diminishes development of herpetic stromal keratitis by antiangiogenic effects. J. Immunol. 175 (2005) 509-516
112. Kintner R.L., and Brandt C.R. The effect of viral inoculum level and host age on disease incidence, disease severity, and mortality in a murine model of ocular HSV-1 infection. Curr. Eye Res. 14 (1995) 145-152
113. Klinman D.M., Ishii K.J., Gursel M., Gursel I., Takeshita S., and Takeshita F. Immunotherapeutic applications of CpG-containing oligodeoxynucleotides. Drug News Perspect. 13 (2000) 289-296
114. Knipe D.M., and Howley P.M. Fields Virology (2001), Lippincot Williams and Wilkins, Philadelphia
115. Kubat N.J., Tran R.K., McAnany P., and Bloom D.C. Specific histone tail modification and not DNA methylation is a determinant of herpes simplex virus type 1 latent gene expression. J. Virol. 78 (2004) 1139-1149
116. Kurt-Jones E.A., Chan M., Zhou S., Wang J., Reed G., Bronson R., Arnold M.M., Knipe D.M., and Finberg R.W. Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc. Natl. Acad. Sci. USA 101 (2004) 1315-1320
117. Langston R.H., and Pavan-Langston D. Penetrating keratoplasty for herpetic keratitis: decision-making and management. Int. Ophthalmol. Clin. 15 (1975) 125-140
118. Lavail J.H., Tauscher A.N., Hicks J.W., Harrabi O., Melroe G.T., and Knipe D.M. Genetic and molecular in vivo analysis of herpes simplex virus assembly in murine visual system neurons. J. Virol. 79 (2005) 11142-11150
119. Lee S., Zheng M., Deshpande S., Eo S.K., Hamilton T.A., and Rouse B.T. IL-12 suppresses the expression of ocular immunoinflammatory lesions by effects on angiogenesis. J. Leukoc. Biol. 71 (2002) 469-476
120. Lee S., Zheng M., Kim B., and Rouse B.T. Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus. J. Clin. Invest. 110 (2002) 1105-1111
121. Leib D.A., Bogard C.L., Kosz-Vnenchak M., Hicks K.A., Coen D.M., Knipe D.M., and Schaffer P.A. A deletion mutant of the latency-associated transcript of herpes simplex virus type 1 reactivates from the latent state with reduced frequency. J. Virol. 63 (1989) 2893-2900
122. Leib D.A., Coen D.M., Bogard C.L., Hicks K.A., Yager D.R., Knipe D.M., Tyler K.L., and Schaffer P.A. Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency. J. Virol. 63 (1989) 759-768
123. Leinbach S.S., and Summers W.C. The structure of herpes simplex virus type 1 DNA as probed by micrococcal nuclease digestion. J. Gen. Virol. 51 (1980) 45-59
124. Liesegang T.J. Epidemiology of ocular herpes simplex: natural history in Rochester, Minn, 1950 through 1982. Arch. Ophthalmol. 107 (1989) 1160-1165
125. Liesegang T.J. Classification of herpes simplex virus keratitis and anterior uveitis. Cornea 18 (1999) 127-143
126. Liesegang T.J. Herpes simplex virus epidemiology and ocular importance. Cornea 20 (2001) 1-13
127. Lilley C.E., Carson C.T., Muotri A.R., Gage F.H., and Weitzman M.D. DNA repair proteins affect the lifecycle of herpes simplex virus 1. Proc. Natl. Acad. Sci. USA 102 (2005) 5844-5849
128. Liu T., Khanna K.M., Chen X., Fink D.J., and Hendricks R.L. CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J. Exp. Med. 191 (2000) 1459-1466
129. Loiacono C.M., Taus N.S., and Mitchell W.J. The herpes simplex virus type 1 ICP0 promoter is activated by viral reactivation stimuli in trigeminal ganglia neurons of transgenic mice. J. Neurovirol. 9 (2003) 336-345
130. Lund J., Sato A., Akira S., Medzhitov R., and Iwasaki A. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198 (2003) 513-520
131. Luster A.D., Greenberg S.M., and Leder P. The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J. Exp. Med. 182 (1995) 219-231
132. Mador N., Panet A., and Steiner I. The latency-associated gene of herpes simplex virus type 1 (HSV-1) interferes with superinfection by HSV-1. J. Neurovirol. 8 Suppl. 2 (2002) 97-102
133. Maggs D.J., Chang E., Nasisse M.P., and Mitchell W.J. Persistence of herpes simplex virus type 1 DNA in chronic conjunctival and eyelid lesions of mice. J. Virol. 72 (1998) 9166-9172
134. Mao H., and Rosenthal K.S. Strain-dependent structural variants of herpes simplex virus type 1 ICP34.5 determine viral plaque size, efficiency of glycoprotein processing, and viral release and neuroinvasive disease potential. J. Virol. 77 (2003) 3409-3417
135. Margolis T.P., and Ostler H.B. Treatment of ocular disease in eczema herpeticum. Am. J. Ophthalmol. 110 (1990) 274-279
136. Maul G.G., and Everett R.D. The nuclear location of PML, a cellular member of the C3HC4 zinc-binding domain protein family, is rearranged during herpes simplex virus infection by the C3HC4 viral protein ICP0. J. Gen. Virol. 75 Part 6 (1994) 1223-1233
137. Maul G.G., Guldner H.H., and Spivack J.G. Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0). J. Gen. Virol. 74 Part 12 (1993) 2679-2690
138. McGeoch D.J., Dolan A., Donald S., and Rixon F.J. Sequence determination and genetic content of the short unique region in the genome of herpes simplex virus type 1. J. Mol. Biol. 181 (1985) 1-13
139. McGeoch D.J., Dalrymple M.A., Davison A.J., Dolan A., Frame M.C., McNab D., Perry L.J., Scott J.E., and Taylor P. The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J. Gen. Virol. 69 Part 7 (1988) 1531-1574
140. McGeoch D.J., Cunningham C., McIntyre G., and Dolan A. Comparative sequence analysis of the long repeat regions and adjoining parts of the long unique regions in the genomes of herpes simplex viruses types 1 and 2. J. Gen. Virol. 72 Part 12 (1991) 3057-3075
141. McGill J., Tormey P., and Walker C.B. Comparative trial of acyclovir and adenine arabinoside in the treatment of herpes simplex corneal ulcers. Br. J. Ophthalmol. 65 (1981) 610-613
142. Mengelle C., Sandres-Saune K., Miedouge M., Mansuy J.M., Bouquies C., and Izopet J. Use of two real-time polymerase chain reactions (PCRs) to detect herpes simplex type 1 and 2-DNA after automated extraction of nucleic acid. J. Med. Virol. 74 (2004) 459-462
143. Metcalf J.F., and Kaufman H.E. Herpetic stromal keratitis-evidence for cell-mediated immunopathogenesis. Am. J. Ophthalmol. 82 (1976) 827-834
144. Meyers-Elliott R.H., Pettit T.H., and Maxwell W.A. Viral antigens in the immune ring of Herpes simplex stromal keratitis. Arch. Ophthalmol. 98 (1980) 897-904
145. Mitchell W.J., Gressens P., Martin J.R., and DeSanto R. Herpes simplex virus type 1 DNA persistence, progressive disease and transgenic immediate early gene promoter activity in chronic corneal infections in mice. J. Gen. Virol. 75 Part 6 (1994) 1201-1210
146. Moyes A.L., Sugar A., Musch D.C., and Barnes R.D. Antiviral therapy after penetrating keratoplasty for herpes simplex keratitis. Arch. Ophthalmol. 112 (1994) 601-607
147. Murray P.R., Rosenthal K.S., Kobayashi G.S., and Pfaller M.A. Medical Microbiology (2002), Mosby, St. Louis
148. Naito J., Mott K.R., Osorio N., Jin L., and Perng G.C. Herpes simplex virus type 1 immediate-early protein ICP0 diffuses out of infected rabbit corneas. J. Gen. Virol. 86 (2005) 2979-2988
149. Neufeld M.V., Steinemann T.L., Merin L.M., Stroop W.G., and Brown M.F. Identification of a herpes simplex virus-induced dendrite in an eye-bank donor cornea. Cornea 18 (1999) 489-492
150. Nicholls S.M., Shimeld C., Easty D.L., and Hill T.J. Recurrent herpes simplex after corneal transplantation in rats. Invest. Ophthalmol. Vis. Sci. 37 (1996) 425-435
151. Nicosia M., Zabolotny J.M., Lirette R.P., and Fraser N.W. The HSV-1 2-kb latency-associated transcript is found in the cytoplasm comigrating with ribosomal subunits during productive infection. Virology 204 (1994) 717-728
152. Norberg P., Bergstrom T., Rekabdar E., Lindh M., and Liljeqvist J.A. Phylogenetic analysis of clinical herpes simplex virus type 1 isolates identified three genetic groups and recombinant viruses. J. Virol. 78 (2004) 10755-10764
153. Norn M.S. Dendritic (herpetic) keratitis, I: incidence-seasonal variations-recurrence rate-visual impairment-therapy. Acta. Ophthalmol. (Copenh) 48 (1970) 91-107
154. Norose K., Yano A., Zhang X.M., Blankenhorn E., and Heber-Katz E. Mapping of genes involved in murine herpes simplex virus keratitis: identification of genes and their modifiers. J. Virol. 76 (2002) 3502-3510
155. O'Brien W.J., Tsao L.S., and Taylor J.L. Tissue-specific accumulation of latency-associated transcripts in herpes virus-infected rabbits. Invest. Ophthalmol. Vis. Sci. 39 (1998) 1847-1853
156. Ohara P.T., Tauscher A.N., and Lavail J.H. Two paths for dissemination of Herpes simplex virus from infected trigeminal ganglion to the murine cornea. Brain Res. 899 (2001) 260-263
157. Ohashi Y., Yamamoto S., Nishida K., Okamoto S., Kinoshita S., Hayashi K., and Manabe R. Demonstration of herpes simplex virus DNA in idiopathic corneal endotheliopathy. Am. J. Ophthalmol. 112 (1991) 419-423
158. Okuda T., Kurokawa M., Matsuo K., Honda M., Niimura M., and Shiraki K. Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus. J. Med. Virol. 72 (2004) 112-120
159. Olsen T.W., Hardten D.R., Meiusi R.S., and Holland E.J. Linear endotheliitis. Am. J. Ophthalmol. 117 (1994) 468-474
160. Oosterhuis J.A., van G.R., and Versteeg J. Acyclovir treatment in stromal herpetic keratitis. Doc. Ophthalmol. 56 (1983) 81-88
161. Openshaw H., McNeill J.I., Lin X.H., Niland J., and Cantin E.M. Herpes simplex virus DNA in normal corneas: persistence without viral shedding from ganglia. J. Med. Virol. 46 (1995) 75-80
162. Pavan-Langston D. Diagnosis and management of herpes simplex ocular infection. Int. Ophthalmol. Clin. 15 (1975) 19-35
163. Penfold M.E., Armati P., and Cunningham A.L. Axonal transport of herpes simplex virions to epidermal cells: evidence for a specialized mode of virus transport and assembly. Proc. Natl. Acad. Sci. USA 91 (1994) 6529-6533
164. Perng G.C., Ghiasi H., Slanina S.M., Nesburn A.B., and Wechsler S.L. The spontaneous reactivation function of the herpes simplex virus type 1 LAT gene resides completely within the first 1.5 kilobases of the 8.3-kilobase primary transcript. J. Virol. 70 (1996) 976-984
165. Perng G.C., Slanina S.M., Yukht A., Drolet B.S., Keleher Jr. W., Ghiasi H., Nesburn A.B., and Wechsler S.L. A herpes simplex virus type 1 latency-associated transcript mutant with increased virulence and reduced spontaneous reactivation. J. Virol. 73 (1999) 920-929
166. Perng G.C., Jones C., Ciacci-Zanella J., Stone M., Henderson G., Yukht A., Slanina S.M., Hofman F.M., Ghiasi H., Nesburn A.B., and Wechsler S.L. Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. Science 287 (2000) 1500-1503
167. Perng G.C., Maguen B., Jin L., Mott K.R., Kurylo J., BenMohamed L., Yukht A., Osorio N., Nesburn A.B., Henderson G., Inman M., Jones C., and Wechsler S.L. A novel herpes simplex virus type 1 transcript (AL-RNA) antisense to the 5' end of the latency-associated transcript produces a protein in infected rabbits. J. Virol. 76 (2002) 8003-8010
168. Perng G.C., Mott K.R., Osorio N., Yukht A., Salina S., Nguyen Q.H., Nesburn A.B., and Wechsler S.L. Herpes simplex virus type 1 mutants containing the KOS strain ICP34.5 gene in place of the McKrae ICP34.5 gene have McKrae-like spontaneous reactivation but non-McKrae-like virulence. J. Gen. Virol. 83 (2002) 2933-2942
169. Perry L.J., Rixon F.J., Everett R.D., Frame M.C., and McGeoch D.J. Characterization of the IE110 gene of herpes simplex virus type 1. J. Gen. Virol. 67 Part 11 (1986) 2365-2380
170. Poffenberger K.L., and Roizman B. A noninverting genome of a viable herpes simplex virus 1: presence of head-to-tail linkages in packaged genomes and requirements for circularization after infection. J. Virol. 53 (1985) 587-595
171. Poirier R.H. Herpetic ocular infections of childhood. Arch. Ophthalmol. 98 (1980) 704-706
172. Polcicova K., Biswas P.S., Banerjee K., Wisner T.W., Rouse B.T., and Johnson D.C. Herpes keratitis in the absence of anterograde transport of virus from sensory ganglia to the cornea. Proc. Natl. Acad. Sci. USA 102 (2005) 11462-11467
173. Quinlan M.P., and Knipe D.M. Stimulation of expression of a herpes simplex virus DNA-binding protein by two viral functions. Mol. Cell Biol. 5 (1985) 957-963
174. Regad T., and Chelbi-Alix M.K. Role and fate of PML nuclear bodies in response to interferon and viral infections. Oncogene 20 (2001) 7274-7286
175. Remeijer L., Doornenbal P., Geerards A.J., Rijneveld W.A., and Beekhuis W.H. Newly acquired herpes simplex virus keratitis after penetrating keratoplasty. Ophthalmology 104 (1997) 648-652
176. Remeijer L., Maertzdorf J., Doornenbal P., Verjans G.M., and Osterhaus A.D. Herpes simplex virus 1 transmission through corneal transplantation. Lancet 357 (2001) 442
177. Remeijer L., Maertzdorf J., Buitenwerf J., Osterhaus A.D., and Verjans G.M. Corneal herpes simplex virus type 1 superinfection in patients with recrudescent herpetic keratitis. Invest. Ophthalmol. Vis. Sci. 43 (2002) 358-363
178. Rixon F.J., Campbell M.E., and Clements J.B. A tandemly reiterated DNA sequence in the long repeat region of herpes simplex virus type 1 found in close proximity to immediate-early mRNA 1. J. Virol. 52 (1984) 715-718
179. Robert P.Y., Adenis J.P., Denis F., Alain S., and Ranger-Rogez S. Herpes simplex virus DNA in corneal transplants: prospective study of 38 recipients. J. Med. Virol. 71 (2003) 69-74
180. Rock D.L., and Fraser N.W. Detection of HSV-1 genome in central nervous system of latently infected mice. Nature 302 (1983) 523-525
181. Rock D.L., Nesburn A.B., Ghiasi H., Ong J., Lewis T.L., Lokensgard J.R., and Wechsler S.L. Detection of latency-related viral RNAs in trigeminal ganglia of rabbits latently infected with herpes simplex virus type 1. J. Virol. 61 (1987) 3820-3826
182. Roizman B. The structure and isomerization of herpes simplex virus genomes. Cell 16 (1979) 481-494
183. Roizman B., and Knipe D.M. Herpes simplex viruses and their replication. Fields Virology (2001), Lippincott Williams and Wilkins, Philadelphia 2399-2459
184. Rong B.L., Pavan-Langston D., Weng Q.P., Martinez R., Cherry J.M., and Dunkel E.C. Detection of herpes simplex virus thymidine kinase and latency-associated transcript gene sequences in human herpetic corneas by polymerase chain reaction amplification. Invest. Ophthalmol. Vis. Sci. 32 (1991) 1808-1815
185. Sabbaga E.M., Pavan-Langston D., Bean K.M., and Dunkel E.C. Detection of HSV nucleic acid sequences in the cornea during acute and latent ocular disease. Exp. Eye Res. 47 (1988) 545-553
186. Samaniego L.A., Neiderhiser L., and DeLuca N.A. Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. J. Virol. 72 (1998) 3307-3320
187. Sandri-Goldin R.M. Replication of the herpes simplex virus genome: does it really go around in circles?. Proc. Natl. Acad. Sci. USA 100 (2003) 7428-7429
188. Schultz G., Chegini N., Grant M., Khaw P., and MacKay S. Effects of growth factors on corneal wound healing. Acta. Ophthalmol. Suppl. 60-66 (1992)
189. Schwab I.R. Oral acyclovir in the management of herpes simplex ocular infections. Ophthalmology 95 (1988) 423-430
190. Schwartz G.S., and Holland E.J. Oral acyclovir for the management of herpes simplex virus keratitis in children. Ophthalmology 107 (2000) 278-282
191. Sears A.E., and Roizman B. Amplification by host cell factors of a sequence contained within the herpes simplex virus 1 genome. Proc. Natl. Acad. Sci. USA 87 (1990) 9441-9444
192. Shimeld C., Hill T., Blyth B., and Easty D. An improved model of recurrent herpetic eye disease in mice. Curr. Eye Res. 8 (1989) 1193-1205
193. Shimeld C., Hill T.J., Blyth W.A., and Easty D.L. Passive immunization protects the mouse eye from damage after herpes simplex virus infection by limiting spread of virus in the nervous system. J. Gen. Virol. 71 Part 3 (1990) 681-687
194. Simon A.L., and Pavan-Langston D. Long-term oral acyclovir therapy: effect on recurrent infectious herpes simplex keratitis in patients with and without grafts. Ophthalmology 103 (1996) 1399-1404
195. Skaliter R., Makhov A.M., Griffith J.D., and Lehman I.R. Rolling circle DNA replication by extracts of herpes simplex virus type 1-infected human cells. J. Virol. 70 (1996) 1132-1136
196. Smith T.J., ckland-Berglund C.E., and Leib D.A. Herpes simplex virus virion host shutoff (vhs) activity alters periocular disease in mice. J. Virol. 74 (2000) 3598-3604
197. Sottile J. Regulation of angiogenesis by extracellular matrix. Biochim. Biophys. Acta. 1654 (2004) 13-22
198. Souza P.M., Holland E.J., and Huang A.J. Bilateral herpetic keratoconjunctivitis. Ophthalmology 110 (2003) 493-496
199. Spear P.G., and Roizman B. Proteins specified by herpes simplex virus, V: purification and structural proteins of the herpesvirion. J. Virol. 9 (1972) 143-159
200. Spencer W.H., and Hayes T.L. Scanning and transmission electron microscopic observations of the topographic anatomy of dendritic lesions in the rabbit cornea. Invest. Ophthalmol. 9 (1970) 183-195
201. Spivack J.G., and Fraser N.W. Expression of herpes simplex virus type 1 latency-associated transcripts in the trigeminal ganglia of mice during acute infection and reactivation of latent infection. J. Virol. 62 (1988) 1479-1485
202. Steiner I., Spivack J.G., O'Boyle D.R., Lavi E., and Fraser N.W. Latent herpes simplex virus type 1 transcription in human trigeminal ganglia. J. Virol. 62 (1988) 3493-3496
203. Stevens J.G. Herpes simplex virus latency analyzed by in situ hybridization. Curr. Top. Microbiol. Immunol. 143 (1989) 1-8
204. Stevens J.G., Wagner E.K., vi-Rao G.B., Cook M.L., and Feldman L.T. RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science 235 (1987) 1056-1059
205. Streilein J.W., Dana M.R., and Ksander B.R. Immunity causing blindness: five different paths to herpes stromal keratitis. Immunol. Today 18 (1997) 443-449
206. Stumpf T.H., Shimeld C., Easty D.L., and Hill T.J. Cytokine production in a murine model of recurrent herpetic stromal keratitis. Invest. Ophthalmol. Vis. Sci. 42 (2001) 372-378
207. Su Y.H., Moxley M.J., Ng A.K., Lin J., Jordan R., Fraser N.W., and Block T.M. Stability and circularization of herpes simplex virus type 1 genomes in quiescently infected PC12 cultures. J. Gen. Virol. 83 (2002) 2943-2950
208. Subhan S., Jose R.J., Duggirala A., Hari R., Krishna P., Reddy S., and Sharma S. Diagnosis of herpes simplex virus-1 keratitis: comparison of Giemsa stain, immunofluorescence assay and polymerase chain reaction. Curr. Eye Res. 29 (2004) 209-213
209. Sundmacher R. [Oral acyclovir therapy of virologically proven intraocular herpes simplex virus infections]. Klin. Monatsbl. Augenheilkd. 183 (1983) 246-250
210. Takahashi G.H., Leibowitz H.M., and Kibrick S. Topically applied steroids in active herpes simplex keratitis. Effect in rabbits. Arch. Ophthalmol. 85 (1971) 350-354
211. Tamesis R.R., Messmer E.M., Rice B.A., Dutt J.E., and Foster C.S. The role of natural killer cells in the development of herpes simplex virus type 1 induced stromal keratitis in mice. Eye 8 Part 3 (1994) 298-306
212. Tang Q., Li L., Ishov A.M., Revol V., Epstein A.L., and Maul G.G. Determination of minimum herpes simplex virus type 1 components necessary to localize transcriptionally active DNA to ND10. J. Virol. 77 (2003) 5821-5828
213. Theil D., Derfuss T., Paripovic I., Herberger S., Meinl E., Schueler O., Strupp M., Arbusow V., and Brandt T. Latent herpesvirus infection in human trigeminal ganglia causes chronic immune response. Am. J. Pathol. 163 (2003) 2179-2184
214. Thomas J., Gangappa S., Kanangat S., and Rouse B.T. On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis. J. Immunol. 158 (1997) 1383-1391
215. Thomas J., Kanangat S., and Rouse B.T. Herpes simplex virus replication-induced expression of chemokines and proinflammatory cytokines in the eye: implications in herpetic stromal keratitis. J. Interferon. Cytokine Res. 18 (1998) 681-690
216. Thomas S.K., Lilley C.E., Latchman D.S., and Coffin R.S. A protein encoded by the herpes simplex virus (HSV) type 1 2-kilobase latency-associated transcript is phosphorylated, localized to the nucleus, and overcomes the repression of expression from exogenous promoters when inserted into the quiescent HSV genome. J. Virol. 76 (2002) 4056-4067
217. Thompson R.L., and Sawtell N.M. The herpes simplex virus type 1 latency-associated transcript gene regulates the establishment of latency. J. Virol. 71 (1997) 5432-5440
218. Thompson R.L., and Sawtell N.M. HSV latency-associated transcript and neuronal apoptosis. Science 289 (2000) 1651
219. Thompson R.L., and Sawtell N.M. Herpes simplex virus type 1 latency-associated transcript gene promotes neuronal survival. J. Virol. 75 (2001) 6660-6675
220. Thompson R.L., Shieh M.T., and Sawtell N.M. Analysis of herpes simplex virus ICP0 promoter function in sensory neurons during acute infection, establishment of latency, and reactivation in vivo. J. Virol. 77 (2003) 12319-12330
221. Thygeson P. Cytologic observations on herpet'c keratitis. Am. J. Ophthalmol. 45 (1958) 240-245
222. Tolsma S.S., Volpert O.V., Good D.J., Frazier W.A., Polverini P.J., and Bouck N. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J. Cell Biol. 122 (1993) 497-511
223. Tomishima M.J., and Enquist L.W. A conserved alpha-herpesvirus protein necessary for axonal localization of viral membrane proteins. J. Cell Biol. 154 (2001) 741-752
224. Tomishima M.J., Smith G.A., and Enquist L.W. Sorting and transport of alpha herpesviruses in axons. Traffic 2 (2001) 429-436
225. Tullo A.B., Shimeld C., Blyth W.A., Hill T.J., and Easty D.L. Spread of virus and distribution of latent infection following ocular herpes simplex in the non-immune and immune mouse. J. Gen Virol. 63 Part 1 (1982) 95-101
226. Tullo A.B., Shimeld C., Blyth W.A., Hill T.J., and Easty D.L. Ocular infection with herpes simplex virus in nonimmune and immune mice. Arch. Ophthalmol. 101 (1983) 961-964
227. Tullo A.B., Easty D.L., Shimeld C., Stirling P.E., and Darville J.M. Isolation of herpes simplex virus from corneal discs of patients with chronic stromal keratitis. Trans. Ophthalmol. Soc. UK 104 Part 2 (1985) 159-165
228. Tumpey T.M., Chen S.H., Oakes J.E., and Lausch R.N. Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J. Virol. 70 (1996) 898-904
229. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., Gromkowski S.H., Deck R.R., DeWitt C.M., and Friedman A. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259 (1993) 1745-1749
230. Umene K. Genetic variability of herpesviruses. Herpesvirus, Genetic Variability and Recombination (1998), Touka Shobo, Fukuoka, Japan 131-157
231. Umene K., Inoue T., Inoue Y., and Shimomura Y. Genotyping of herpes simplex virus type 1 strains isolated from ocular materials of patients with herpetic keratitis. J. Med. Virol. 71 (2003) 75-81
232. Umene K., and Sakaoka H. Evolution of herpes simplex virus type 1 under herpesviral evolutionary processes. Arch. Virol. 144 (1999) 637-656
233. Vailhe B., and Feige J.J. Thrombospondins as anti-angiogenic therapeutic agents. Curr. Pharm. Des. 9 (2003) 583-588
234. van R.J., Rijneveld W.J., Remeijer L.J., and Beekhuis W.H. A retrospective study on the effectiveness of oral acyclovir to prevent herpes simplex recurrence in corneal grafts. Eur. J. Ophthalmol. 5 (1995) 214-218
235. van R.J., Rijneveld W.J., Remeijer L., Volker-Dieben H.J., Eggink C.A., Geerards A.J., Mulder P.G., Doornenbal P., and Beekhuis W.H. Effect of oral acyclovir after penetrating keratoplasty for herpetic keratitis: a placebo-controlled multicenter trial. Ophthalmology 110 (2003) 1916-1919
236. Wang Q.Y., Zhou C., Johnson K.E., Colgrove R.C., Coen D.M., and Knipe D.M. Herpesviral latency-associated transcript gene promotes assembly of heterochromatin on viral lytic-gene promoters in latent infection. Proc. Natl. Acad. Sci. USA 102 (2005) 16055-16059
237. Wechsler S.L., Nesburn A.B., Watson R., Slanina S.M., and Ghiasi H. Fine mapping of the latency-related gene of herpes simplex virus type 1: alternative splicing produces distinct latency-related RNAs containing open reading frames. J. Virol. 62 (1988) 4051-4058
238. Wechsler S.L., Nesburn A.B., Zwaagstra J., and Ghiasi H. Sequence of the latency-related gene of herpes simplex virus type 1. Virology 168 (1989) 168-172
239. Wilhelmus K.R. Diagnosis and management of herpes simplex stromal keratitis. Cornea 6 (1987) 286-291
240. Wilhelmus K.R., Coster D.J., Donovan H.C., Falcon M.G., and Jones B.R. Prognosis indicators of herpetic keratitis: analysis of a five-year observation period after corneal ulceration. Arch. Ophthalmol. 99 (1981) 1578-1582
241. Wilhelmus K.R., Falcon M.G., and Jones B.R. Bilateral herpetic keratitis. Br. J. Ophthalmol. 65 (1981) 385-387
242. Wilhelmus K.R., Gee L., Hauck W.W., Kurinij N., Dawson C.R., Jones D.B., Barron B.A., Kaufman H.E., Sugar J., and Hyndiuk R.A. Herpetic Eye Disease Study: a controlled trial of topical corticosteroids for herpes simplex stromal keratitis. Ophthalmology 101 (1994) 1883-1895
243. Wishart M.S., Darougar S., and Viswalingam N.D. Recurrent herpes simplex virus ocular infection: epidemiological and clinical features. Br. J. Ophthalmol. 71 (1987) 669-672
244. WuDunn D., and Spear P.G. Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J. Virol. 63 (1989) 52-58
245. Yang Y.N., Bauer D., Wasmuth S., Steuhl K.P., and Heiligenhaus A. Matrix metalloproteinases (MMP-2 and 9) and tissue inhibitors of matrix metalloproteinases (TIMP-1 and 2) during the course of experimental necrotizing herpetic keratitis. Exp. Eye Res. 77 (2003) 227-237
246. York I.A., Roop C., Andrews D.W., Riddell S.R., Graham F.L., and Johnson D.C. A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell 77 (1994) 525-535
247. Zhao Z.S., Granucci F., Yeh L., Schaffer P.A., and Cantor H. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science 279 (1998) 1344-1347
248. Zheng M., Deshpande S., Lee S., Ferrara N., and Rouse B.T. Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis. J. Virol. 75 (2001) 9828-9835
249. Zheng M., Klinman D.M., Gierynska M., and Rouse B.T. DNA containing CpG motifs induces angiogenesis. Proc. Natl. Acad. Sci. USA 99 (2002) 8944-8949
250. Zheng M., Schwarz M.A., Lee S., Kumaraguru U., and Rouse B.T. Control of stromal keratitis by inhibition of neovascularization. Am. J. Pathol. 159 (2001) 1021-1029
251. Zwaagstra J., Ghiasi H., Nesburn A.B., and Wechsler S.L. In vitro promoter activity associated with the latency-associated transcript gene of herpes simplex virus type 1. J. Gen. Virol. 70 Part 8 (1989) 2163-2169
252. Zwaagstra J.C., Ghiasi H., Slanina S.M., Nesburn A.B., Wheatley S.C., Lillycrop K., Wood J., Latchman D.S., Patel K., and Wechsler S.L. Activity of herpes simplex virus type 1 latency-associated transcript (LAT) promoter in neuron-derived cells: evidence for neuron specificity and for a large LAT transcript. J. Virol. 64 (1990) 5019-5028